ABT vs PNTG · P/E 25, rev $44.33B vs P/E 40, rev $583.3M
Abbott Laboratories (ABT) versus Pennant Group Inc (PNTG) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Pennant Group Inc (PNTG) is a medical care facilities company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported PNTG revenue for 2026-06-30 was $583.3M. Net income was $17.6M. PNTG currently screens at market cap $1.20B and trailing P/E 40.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PNTG currently screens at market cap $1.20B and trailing P/E 40.2.
Not investment advice. Open the ABT and PNTG stock pages for the full models.
Not investment advice.